Sintx Technologies, Inc. (SINT)
USD 3.89
(26.71%)
USD 3.89
(26.71%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.24 Million USD | 47.04% |
| 2022 | 2.88 Million USD | 20.39% |
| 2021 | 2.39 Million USD | 5.36% |
| 2020 | 2.27 Million USD | 1.38% |
| 2019 | 2.24 Million USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 2.96 Million USD | -57.77% |
| 2016 | 7.01 Million USD | -58.65% |
| 2015 | 16.95 Million USD | -23.38% |
| 2014 | 22.13 Million USD | 23.46% |
| 2013 | 17.92 Million USD | -12.41% |
| 2012 | 20.46 Million USD | -53.47% |
| 2011 | 43.98 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 4.29 Million USD | 1.25% |
| 2024 Q2 | 4.16 Million USD | -3.12% |
| 2023 Q3 | 1.91 Million USD | -13.9% |
| 2023 Q1 | 2.44 Million USD | -15.24% |
| 2023 Q2 | 2.22 Million USD | -9.15% |
| 2023 Q4 | 4.24 Million USD | 121.79% |
| 2023 FY | 4.24 Million USD | 47.04% |
| 2022 FY | 2.88 Million USD | 20.39% |
| 2022 Q4 | 2.88 Million USD | 4.19% |
| 2022 Q1 | 2.8 Million USD | 16.76% |
| 2022 Q3 | 2.77 Million USD | -5.36% |
| 2022 Q2 | 2.92 Million USD | 4.57% |
| 2021 Q2 | 2.19 Million USD | -4.53% |
| 2021 Q4 | 2.39 Million USD | -20.39% |
| 2021 FY | 2.39 Million USD | 5.36% |
| 2021 Q3 | 3.01 Million USD | 37.41% |
| 2021 Q1 | 2.29 Million USD | 0.88% |
| 2020 Q1 | 2.17 Million USD | -3.3% |
| 2020 FY | 2.27 Million USD | 1.38% |
| 2020 Q2 | 2.48 Million USD | 14.51% |
| 2020 Q4 | 2.27 Million USD | -3.93% |
| 2020 Q3 | 2.36 Million USD | -4.71% |
| 2019 Q4 | 2.24 Million USD | -8.55% |
| 2019 FY | 2.24 Million USD | 0.0% |
| 2019 Q3 | 2.45 Million USD | -6.9% |
| 2019 Q2 | 2.63 Million USD | 268.81% |
| 2019 Q1 | 715 Thousand USD | 323.08% |
| 2018 Q3 | 2.5 Million USD | 0.85% |
| 2018 Q4 | 169 Thousand USD | -93.24% |
| 2018 FY | - USD | -100.0% |
| 2018 Q1 | 4.51 Million USD | 52.41% |
| 2018 Q2 | 2.47 Million USD | -45.07% |
| 2017 Q3 | 4.61 Million USD | 16.31% |
| 2017 Q1 | 5.48 Million USD | -21.82% |
| 2017 FY | 2.96 Million USD | -57.77% |
| 2017 Q4 | 2.96 Million USD | -35.83% |
| 2017 Q2 | 3.96 Million USD | -27.64% |
| 2016 Q3 | 8.48 Million USD | -23.91% |
| 2016 Q4 | 7.01 Million USD | -17.35% |
| 2016 FY | 7.01 Million USD | -58.65% |
| 2016 Q1 | 14.78 Million USD | -12.81% |
| 2016 Q2 | 11.15 Million USD | -24.59% |
| 2015 Q4 | 16.95 Million USD | -15.1% |
| 2015 Q2 | 22.54 Million USD | 1.25% |
| 2015 Q3 | 19.97 Million USD | -11.41% |
| 2015 Q1 | 22.26 Million USD | 0.61% |
| 2015 FY | 16.95 Million USD | -23.38% |
| 2014 Q2 | 20.11 Million USD | 24.7% |
| 2014 Q3 | 22.7 Million USD | 12.86% |
| 2014 Q4 | 22.13 Million USD | -2.52% |
| 2014 FY | 22.13 Million USD | 23.46% |
| 2014 Q1 | 16.13 Million USD | -10.0% |
| 2013 Q4 | 17.92 Million USD | 0.05% |
| 2013 Q2 | 19.17 Million USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 17.92 Million USD | -12.41% |
| 2013 Q3 | 17.91 Million USD | -6.58% |
| 2012 Q4 | 20.46 Million USD | 0.0% |
| 2012 FY | 20.46 Million USD | -53.47% |
| 2011 FY | 43.98 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.216% |
| Nemaura Medical Inc. | 20.03 Million USD | 78.807% |
| NeuroPace, Inc. | 72.39 Million USD | 94.136% |
| LENSAR, Inc. | 2.3 Million USD | -83.846% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 42.213% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -166.144% |
| Apyx Medical Corporation | 38.5 Million USD | 88.974% |
| Cutera, Inc. | 431.91 Million USD | 99.017% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 72.846% |
| BioSig Technologies, Inc. | 452 Thousand USD | -839.159% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 89.176% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.748% |
| Axonics, Inc. | 27.61 Million USD | 84.629% |
| IRIDEX Corporation | 2.74 Million USD | -54.588% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 94.64% |
| TELA Bio, Inc. | 42.78 Million USD | 90.077% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -1050.407% |
| RxSight, Inc. | 3.01 Million USD | -40.936% |
| Align Technology, Inc. | 96.96 Million USD | 95.622% |
| INVO Bioscience, Inc. | 8.68 Million USD | 51.115% |
| electroCore, Inc. | 626 Thousand USD | -578.115% |
| Telesis Bio, Inc. | 34.38 Million USD | 87.653% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 58.671% |
| Quipt Home Medical Corp. | 98.94 Million USD | 95.71% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 85.381% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -80.792% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 72.173% |
| Dynatronics Corporation | 6.68 Million USD | 36.528% |
| Modular Medical, Inc. | 1.19 Million USD | -256.723% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -1520.229% |
| Talis Biomedical Corporation | 19.66 Million USD | 78.417% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -210.98% |
| InMode Ltd. | 9.01 Million USD | 52.922% |
| Envoy Medical, Inc. | 404 Thousand USD | -950.743% |
| Bruker Corporation | 1.37 Billion USD | 99.692% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -7347.368% |
| DexCom, Inc. | 2.59 Billion USD | 99.836% |
| Nexalin Technology, Inc. | 4463.00 USD | -95015.393% |
| PAVmed Inc | 48.72 Million USD | 91.288% |
| Viveve Medical, Inc. | 5.34 Million USD | 20.639% |
| Cerus Corporation | 95.99 Million USD | 95.578% |
| Movano Inc. | 252 Thousand USD | -1584.524% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 87.204% |
| Nexalin Technology, Inc. | 4463.00 USD | -95015.393% |
| IceCure Medical Ltd | 599 Thousand USD | -608.681% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 98.979% |
| enVVeno Medical Corporation | 1.4 Million USD | -202.782% |
| 908 Devices Inc. | 5.94 Million USD | 28.595% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 69.55% |
| Orthofix Medical Inc. | 134.19 Million USD | 96.837% |
| Surmodics, Inc. | 29.4 Million USD | 85.564% |
| Nuwellis, Inc. | 981 Thousand USD | -332.722% |
| Outset Medical, Inc. | 136.18 Million USD | 96.883% |
| Venus Concept Inc. | 79.69 Million USD | 94.674% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 96.73% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 93.962% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 49.44% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -351.444% |
| Inogen, Inc. | 21.92 Million USD | 80.637% |
| IRadimed Corporation | 2.04 Million USD | -107.778% |
| MaxCyte, Inc. | 18.74 Million USD | 77.352% |
| Pulmonx Corporation | 41.42 Million USD | 89.752% |
| PAVmed Inc. | 48.72 Million USD | 91.288% |
| iCAD, Inc. | 461 Thousand USD | -820.824% |
| OrthoPediatrics Corp. | 23.76 Million USD | 82.134% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -112.622% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -762.821% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -2202.061% |
| SI-BONE, Inc. | 38.99 Million USD | 89.113% |
| Semler Scientific, Inc. | 70 Thousand USD | -5964.286% |
| Beyond Air, Inc. | 17.83 Million USD | 76.201% |
| FONAR Corporation | 41.67 Million USD | 89.814% |
| AxoGen, Inc. | 69.29 Million USD | 93.874% |
| Biotricity, Inc. | 23.87 Million USD | 82.223% |
| Cytosorbents Corporation | 18.31 Million USD | 76.82% |
| ZimVie Inc. | 521.92 Million USD | 99.187% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 91.573% |
| Inari Medical, Inc. | 32.04 Million USD | 86.754% |
| UFP Technologies, Inc. | 46.03 Million USD | 90.779% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -112.622% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -38.226% |
| Sight Sciences, Inc. | 35.41 Million USD | 88.013% |
| Insulet Corporation | 1.44 Billion USD | 99.707% |
| Profound Medical Corp. | 7.9 Million USD | 46.268% |
| Bioventus Inc. | 409.47 Million USD | 98.963% |
| InspireMD, Inc. | 1.59 Million USD | -166.144% |
| BrainsWay Ltd. | 471 Thousand USD | -801.274% |
| BIOLASE, Inc. | 17.91 Million USD | 76.298% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -309.615% |
| Tenon Medical, Inc. | 1.17 Million USD | -261.893% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -323.653% |
| CVRx, Inc. | 30.61 Million USD | 86.133% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.815% |
| Acutus Medical, Inc. | 38.47 Million USD | 88.968% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -112.782% |
| NanoVibronix, Inc. | 5000.00 USD | -84800.0% |
| Quanterix Corporation | 41.46 Million USD | 89.762% |
| LivaNova PLC | 640.4 Million USD | 99.337% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -41.946% |
| Varex Imaging Corporation | 469.5 Million USD | 99.096% |
| Vivani Medical, Inc. | 20.69 Million USD | 79.489% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -80.792% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -442.146% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.545% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.177% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -123.069% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -1662.318% |
| Spectral AI, Inc. | 1.28 Million USD | -229.325% |
| Hyperfine, Inc. | 185 Thousand USD | -2194.595% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 97.792% |
| Biomerica, Inc. | 785 Thousand USD | -440.764% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -844.418% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -1046.972% |
| Silk Road Medical, Inc | 84.63 Million USD | 94.984% |